Callery, LLC (Evans City, Pa.; www.callery.com) is the name of the new standalone entity born from BASF’s divestment of its Inorganic Specialties business. The divestiture was facilitated by Edgewater Capital in combination with the Callery management team. Callery is a global leader in highly reactive chemistries, supplying products to the pharmaceutical, fine, and specialty chemical arenas.
Callery’s current product portfolio includes a range of Specialty Alkoxide bases & Borane derivatives, as well as a variety of custom products based on the company’s core competency in the handling of highly reactive compounds. Callery’s world-class facility includes R&D labs, pilot plant, large-scale production facilities and all knowledge associated with existing and developmental products.
Soon, Callery will be announcing its new management team to lead the company on its growth path in the coming years. The company is committed to the continued delivery of innovative products that enable customer success.